CME vs NDAQ
Cme Group Inc. (CME) and Nasdaq, Inc. (NDAQ) are both filed with the SEC under Security & Commodity Brokers, Dealers, Exchanges & Services. CME is 1.8× NDAQ's size by market cap ($101.2B against $55.5B); NDAQ trades at the higher fiscal-year P/E (32.2× against 25.2×); CME reports the higher net margin (62.5% against 21.6%); NDAQ grew sales faster over three years (+9.9% against +9.1%); and over the past year CME returned +10.7% against NDAQ's +5.6%.
| CME | NDAQ | |
|---|---|---|
| Last close | $285.80 | $99.31 |
| Market cap | $101.2B | $55.5B |
| P/E (FY) | 25.2× | 32.2× |
| P/S | 15.5× | 6.7× |
| EV/EBITDA | — | 25.8× |
| Gross margin | — | 63.5% |
| Operating margin | 64.9% | 28.2% |
| Net margin | 62.5% | 21.6% |
| Return on equity | 14.8% | 15.3% |
| Sales growth (3y) | +9.1% | +9.9% |
| EPS growth (3y) | +14.7% | +11.0% |
| Dividend yield | 3.9% | 1.1% |
| 1-year return | +10.7% | +5.6% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year — FY2025 (ended 2025-12-31) for both. — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| CME | NDAQ | |
|---|---|---|
| Institutional holders (13F) | 1,782 | 1,085 |
| Insider buyers − sellers (180d) | -4 | -5 |
| Congressional trades disclosed (180d) | 2 | 8 |
| Executive-branch officials on file — trades disclosed (180d) | 9 | 2 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
CME vs NDAQ: common questions
- Is CME bigger than NDAQ?
- CME carries the larger market cap — $101.2B against $55.5B, both struck on 2026-08-27.
- Which trades at a higher P/E, CME or NDAQ?
- NDAQ, at a fiscal-year 32.2× against 25.2× for CME. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have CME and NDAQ performed over the past year?
- CME returned +10.7% and NDAQ +5.6%, measured on the trailing calendar year to the last close.
- How many institutions hold CME and NDAQ?
- 1,782 13F filers report a position in CME and 1,085 in NDAQ, on the latest quarter in the panel.
- Are CME and NDAQ in the same industry?
- Both are filed with the SEC under Security & Commodity Brokers, Dealers, Exchanges & Services, which is the classification this pairing is built on.
CME overview → · NDAQ overview → · CME institutional ownership → · NDAQ institutional ownership → · Congress and CME → · Congress and NDAQ → · Executive branch and CME → · Executive branch and NDAQ →
More in Security & Commodity Brokers, Dealers, Exchanges & Services: CBOE vs CME · CBOE vs ICE · CBOE vs NDAQ · CBOE vs TW
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/cme-vs-ndaq